Govt Job for M.Pharm, M.Sc as Junior Research Fellow at NIAB

NIAB is an autonomous and premier institute of the Department of Biotechnology (DBT), Government of India.

The Institute aims to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

Walk-in interview for One position of JRF under DBT funded project entitled “Molecular platform for epidemiology, disease mapping and development of diagnostics for economically important diseases of ducks” of Dr. Madhuri Subbiah (non-NER PI) initially for a period of less than three months.

Post : Junior Research Fellow

Fellowship amount : Rs. 31,000 +24% HRA.

Eligibility : Post Graduate degree in professional courses (M.Pharm / M. Tech in Life Sciences / M. V. Sc. etc.) or Post Graduate Degree in Life Sciences (Biotechnology/Biochemistry/Microbiology) with NET qualification.

Desired Experience : Molecular Biology techniques. Candidates having prior experience in molecular techniques involving nucleic acid isolation, quantification, amplification and with cell culture experiences will be preferred

Upper Age limit : 30 years

Interested eligible candidates are advised to attend the online walk-in interview on 23-07-2021 from 02:00 pm to 05:00 pm.

Those interested are requested to kindly email a photograph and copies of documents in support of date of birth, educational qualifications, experience certificates etc. to madhuri@niab.org.in at least two days in advance of the above interview date. Online Interview Link will be sent to the candidates.

Related Posts

GSK Pharma forays into gynaecological cancer treatment in India

GlaxoSmithKline Pharmaceuticals Ltd. stock zoomed as much as 2% on Monday, August 25. This movement in shares came after the company announced its entry into the oncology segment in India…

Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

Hyderabad:  Chief Minister A Revanth Reddy said Hyderabad was India’s emerging hub of biotech, pharma, and medical technology innovation, with the ambition to become a $1 trillion economy by 2034.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

GSK Pharma forays into gynaecological cancer treatment in India

GSK Pharma forays into gynaecological cancer treatment in India

Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

DCGI issued alert regarding theft of Novo Nordisk injectables

DCGI issued alert regarding theft of Novo Nordisk injectables

Two firms fined for selling spurious cosmetic products

Two firms fined for selling spurious cosmetic products